Homepage: Current Issues in Venous Thromboembolism – Postgraduate Medicine Editorial: Current issues in venous thromboembolism A review of upper extremity deep vein thrombosis Outpatient treatment of emergency department patients diagnosed with venous thromboembolism Venous thromboembolism prophylaxis in high-risk orthopedic and cancer surgery Prophylaxis and treatment of COVID-19 related venous thromboembolism Challenges in the diagnostic approach […]
The post Supplement: Current Issues in Venous Thromboembolism. appeared first on Links Medicus.
Homepage: Interstitial Lung Disease 2021 (free registration required for all articles) Disease pathology in fibrotic interstitial lung disease: is it all about usual interstitial pneumonia? Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities Treatment of fibrotic interstitial lung disease: current approaches and future directions Interstitial lung diseases: quo vadis? Moving beyond usual interstitial […]
The post The Lancet Series: Interstitial Lung Disease 2021. appeared first on Links Medicus.
The prevalence of adaptive immunity to COVID-19 and reinfection after recovery, a comprehensive systematic review and meta-analysis of 12 011 447 individuals – medRxiv Commentary on Twitter A new systematic review of over 12 million people from 54 studies at up to 8 months following Covid. >90% prevalence of IgG antibodies, reinfection 0.2% (an […]
The post [Preprint] M-A of 12.011.447 individuals finds individuals previously infected with SARS-CoV-2 had an 81% reduction in odds of a reinfection. appeared first on Links Medicus.
Immunity Is The Only Way Through A Pandemic (w/Dr. Monica Gandhi) – ZDoggMD
The post Opinion | Video: Immunity is the only way through a pandemic (w/Dr. Monica Gandhi). appeared first on Links Medicus.
Secondary infections in critically ill patients with COVID-19 Tracheostomy for COVID-19: evolving best practice See also: Non-Covid articles
The post Annual Update in Intensive Care and Emergency Medicine 2021 – Covid articles. appeared first on Links Medicus.
Influence of age on the effectiveness and duration of protection in Vaxzevria and CoronaVac vaccines – medRxiv
The post [Preprint] Large cohort study in Brazil showed AstraZeneca vaccine had high overall effectiveness against severe disease to individuals up to 89 years of age. In comparison, CoronaVac had high overall effectiveness against severe disease in individuals up to 79 years. appeared first on Links Medicus.
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002) – The Lancet Invited commentary: Longer intervals and extra doses of ChAdOx1 nCoV-19 vaccine Commentaries on Twitter (thread – click for more) Substudy suggests extended interval […]
The post Extended intervals and extra doses of the AstraZeneca vaccine are associated with increased immunogenicity. appeared first on Links Medicus.
How coronavirus spreads through a population and how we can beat it – The Guardian
The post Interactive infographic showing the effects of Delta: How coronavirus spreads through a population and how we can beat it. appeared first on Links Medicus.
Surveillance for Adverse Events After COVID-19 mRNA Vaccination – JAMA Editorial: Safety Surveillance of COVID-19 mRNA Vaccines Through the Vaccine Safety Datalink – JAMA Commentaries: mRNA COVID vaccines not tied to serious side effects – CIDRAP Researchers find no serious health effects linked to mRNA COVID-19 vaccines – News Medical Commentary on Twitter Concerned […]
The post Large surveillance study finds severe adverse events after COVID-19 mRNA vaccination are rare. appeared first on Links Medicus.
Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce – New England Journal of Medicine Related: Another study shows Pfizer mRNA vaccine immunity is reduced over time. Study shows AstraZeneca and Pfizer vaccines are effective against Delta variant, but both doses are needed. Commentary on Twitter (thread – click for more) ? […]
The post The resurgence of SARS-CoV-2 infection in a highly vaccinated health system workforce; vaccine effectiveness against infection was reduced from above 90% from March through June to 65% in July. appeared first on Links Medicus.